Research graph
References from Pertussis: taking aim at the nose in schoolchildren. Local targets link to admitted publications; unresolved targets remain external evidence.
Unresolved reference
2025 · External reference
Waning protection after fifth dose of acellular pertussis vaccine in children
10.1056/nejmoa1200850 · 2012 · External reference
Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model
10.1073/pnas.1314688110 · 2014 · External reference
Unresolved reference
2026 · External reference
Pertactin-deficient Bordetella pertussis isolates: evidence of increased circulation in Europe, 1998 to 2015
10.2807/1560-7917.es.2019.24.7.1700832 · 2019 · External reference
Immunogenicity and safety of BPZE1, an intranasal live attenuated pertussis vaccine, versus tetanus–diphtheria–acellular pertussis vaccine: a randomised, double-blind, phase 2b trial
10.1016/s0140-6736(22)02644-7 · 2023 · External reference
Efficacy, immunogenicity, and safety of the live attenuated nasal pertussis vaccine, BPZE1, in the UK: a randomised, placebo-controlled, phase 2b trial using a controlled human infection model with virulent Bordetella pertussis
10.1016/j.lanmic.2025.101211 · 2025 · External reference
IL-17-dependent SIgA-mediated protection against nasal Bordetella pertussis infection by live attenuated BPZE1 vaccine
10.1038/s41385-018-0073-9 · 2018 · External reference
An alternative route to pertussis protection?
10.1016/s0140-6736(23)00225-8 · 2023 · External reference
The potential public health benefit of live-attenuated pertussis vaccines
10.1080/17425247.2025.2590740 · 2026 · External reference
